Transhepatic endovascular portal vein embolization before hepatectomy

Basit Öğe Kaydı
dc.contributor.authorAltay, Cetin Murat
dc.contributor.authorTopcuoglu, Osman Melih
dc.contributor.authorAlpar, Ayhan
dc.contributor.authorKüçükay, Murat Bülent
dc.contributor.authorKüçükay, Fahrettin
dc.contributor.authorTemel, Tuncer
dc.date.accessioned2024-09-29T16:33:27Z
dc.date.available2024-09-29T16:33:27Z
dc.date.issued2018
dc.departmentKarabük Üniversitesien_US
dc.description.abstractBackground and Aims: To evaluate the safety and efficacy of transhepaticportal vein embolization with Embosphere, Gelfoam, and Amplatzervascular plug II before extended hepatectomy in patients withmetastatic liver disease. Materials and Methods: Between January2008 and October 2014, patients with metastatic liver disease, whowere treated with transhepatic endovascular portal vein embolizationbefore extended hepatectomy to increase the future remnant liver volume,were retrospectively evaluated. Multidetector computed tomographywas utilized before and after the hepatectomy to calculate thefuture remnant liver volume. Ipsilateral portal vein embolization wasperformed in all patients with a microspheric embolic agent (Embosphere,700–900 µm), gelatin foam (Gelfoam), and Amplatzer vascularplug II. Primary outcome measures are the increase in the percentageof the future remnant liver volume, procedure-related mortality andmorbidity, and both technical and clinical success rates. Results: Fourteen(78%) right portal vein and 4 (22%) left portal vein embolizationswere performed in a total of 18 patients (12 men and 6 women) witha mean age of 48±10.1 years (range, 32 to 59 years). The mean increasein the future remnant liver volume at 6 weeks was 41.6±6.7%(range, 35% to 45%), which was sufficient for extended hepatectomy,and the clinical success rate was 100%. The technical success rate was100%, and there was no procedure-related mortality. A self-limitedsubcapsular hematoma occurred in one patient (5%). There was norecanalization of embolized portal veins during follow-ups. Conclusion:Transhepatic portal vein embolization with Embosphere, Gelfoam, andAmplatzer vascular plug II before extended hepatectomy in patientswith metastatic liver disease, is a safe and effective procedure.en_US
dc.identifier.endpage37en_US
dc.identifier.issn1303-6629
dc.identifier.issue1en_US
dc.identifier.startpage33en_US
dc.identifier.trdizinid298657en_US
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/298657
dc.identifier.urihttps://hdl.handle.net/20.500.14619/11901
dc.identifier.volume17en_US
dc.indekslendigikaynakTR-Dizinen_US
dc.language.isoenen_US
dc.relation.ispartofAkademik Gastroenteroloji Dergisien_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectGastroenteroloji ve Hepatolojien_US
dc.titleTranshepatic endovascular portal vein embolization before hepatectomyen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

TR-Dizin İndeksli Yayınlar Koleksiyonu